In adults with MI and LVEF >40% after invasive care, b-blocker therapy did not reduce a composite adverse outcome at a median 3.7 y

Orly Leiva, Islam Y. Elgendy

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)JC134-JC135
JournalAnnals of Internal Medicine
Volume178
Issue number12
DOIs
StatePublished - Dec 2025

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint

Dive into the research topics of 'In adults with MI and LVEF >40% after invasive care, b-blocker therapy did not reduce a composite adverse outcome at a median 3.7 y'. Together they form a unique fingerprint.

Cite this